Complement C5/C5a in the diagnosis and treatment of Graves<b>'</b> ophthalmopathy: A Mendelian randomized study.
Elevated levels of C5/C5a significantly increase the risk of developing Graves' ophthalmopathy. Targeting complement C5 with inhibitors may effectively reduce the risk of Graves' ophthalmopathy.
Authors
- Changci Chenzhao
- Haiyan Chen (ORCID: https://orcid.org/0000-0001-5012-6865)
- Min Zhu (ORCID: https://orcid.org/0009-0006-5345-6951)
- Bingxuan Wu
- Wei Xiong (ORCID: https://orcid.org/0000-0002-5645-1631)
Institutions
- Central South University (CN)
- Third Xiangya Hospital (CN)
Publication Details
- Journal
- PubMed
- Published
- 2024-10-28
- DOI
- https://doi.org/10.11817/j.issn.1672-7347.2024.240062
- Primary Topic
- Toxin Mechanisms and Immunotoxins
- Type
- article
- Field-Weighted Citation Impact
- 0.00